CDI-Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Tops Revenue Estimates

Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of$ 0.34. This compares to loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 26.47%. A quarter ago, it was expected that this company would post a loss of$ 0.21 per share when it actually produced a loss of $0.31, delivering a surprise of -47.62%. Over the last four quarters, the company has ...